Related Experiment Video
Updated: Jun 7, 2025

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
Published on: May 10, 2017
[Pregabalin in prisons: recommendations for the general practitioner]
Jalel Araiedh1,2, Didier Delessert2, Yasser Khazaal1
1Service de médecine des addictions, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Abstract:
The misuse of pregabalin (Lyrica) has emerged as a common problem in recent years, particularly among vulnerable populations. This reality is reflected in the prison environment, where pregabalin is subject to abuse and trafficking. In this article, we detail the issues surrounding this misuse and our practical strategy for tackling it. It is based on four axes: a) clarification of the indication (or lack thereof); b) support of withdrawal with gabapentin; c) if applicable, management of the symptoms or diseases mentioned (neuropathic pain, epilepsy, etc.) with other treatments, and finally d) addiction counseling.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Analgesia and Pain Management
CNS Depressants: Barbiturates and Benzodiazepines
Antiepileptic Drugs: Glutamate Antagonists

